Triostat is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Liothyronine Sodium.
| Product ID | 42023-120_480ffe8b-5e43-45bc-be8b-bc5731cfbe6d | 
| NDC | 42023-120 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Triostat | 
| Generic Name | Liothyronine Sodium | 
| Dosage Form | Injection | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2013-05-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020105 | 
| Labeler Name | Par Pharmaceutical, Inc. | 
| Substance Name | LIOTHYRONINE SODIUM | 
| Active Ingredient Strength | 10 ug/mL | 
| Pharm Classes | l-Triiodothyronine [EPC],Triiodothyronine [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2013-05-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020105 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2013-05-01 | 
| Marketing Category | NDA | 
| Application Number | NDA020105 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2013-05-01 | 
| Ingredient | Strength | 
|---|---|
| LIOTHYRONINE SODIUM | 10 ug/mL | 
| SPL SET ID: | 4cd4baf4-18d2-434f-b80b-4f4b19996cf9 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 42023-120 | Triostat | liothyronine sodium | 
| 50090-0413 | Cytomel | liothyronine sodium | 
| 43742-0956 | Liothyronine | Liothyronine Sodium | 
| 0093-2178 | Liothyronine Sodium | Liothyronine Sodium | 
| 0093-2179 | Liothyronine Sodium | Liothyronine Sodium | 
| 0093-2180 | Liothyronine Sodium | Liothyronine Sodium | 
| 0179-0238 | Liothyronine Sodium | Liothyronine Sodium | 
| 0574-0220 | Liothyronine Sodium | Liothyronine Sodium | 
| 0574-0222 | Liothyronine Sodium | Liothyronine Sodium | 
| 0574-0223 | Liothyronine Sodium | Liothyronine Sodium | 
| 16714-166 | Liothyronine sodium | Liothyronine sodium | 
| 16714-167 | Liothyronine sodium | Liothyronine sodium | 
| 16714-168 | Liothyronine sodium | Liothyronine sodium | 
| 33261-964 | Liothyronine Sodium | Liothyronine Sodium | 
| 39822-0151 | Liothyronine Sodium | Liothyronine Sodium | 
| 42291-417 | Liothyronine Sodium | Liothyronine Sodium | 
| 42291-418 | Liothyronine Sodium | Liothyronine Sodium | 
| 42291-419 | Liothyronine Sodium | Liothyronine Sodium | 
| 42794-018 | Liothyronine Sodium | Liothyronine Sodium | 
| 42794-019 | Liothyronine Sodium | Liothyronine Sodium | 
| 42794-020 | Liothyronine Sodium | Liothyronine Sodium | 
| 43063-252 | Liothyronine Sodium | Liothyronine Sodium | 
| 43063-253 | Liothyronine Sodium | Liothyronine Sodium | 
| 43063-884 | Liothyronine Sodium | Liothyronine Sodium | 
| 50090-3131 | Liothyronine Sodium | Liothyronine Sodium | 
| 50090-5586 | Liothyronine sodium | Liothyronine sodium | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  TRIOSTAT  74192885  1915772 Live/Registered | PAR PHARMACEUTICAL, INC. 1991-08-07 | 
|  TRIOSTAT  72108054  0729439 Dead/Expired | LE PORTE-ECHAPPEMENT UNIVERSEL S.A. (THE UNIVERSAL ESCAPEMENT LTD) 1960-11-08 |